Robert Bond

Array ( [id] => 3730544 [patent_doc_number] => 05670644 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Acridan compounds' [patent_app_type] => 1 [patent_app_number] => 8/647383 [patent_app_country] => US [patent_app_date] => 1996-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12421 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670644.pdf [firstpage_image] =>[orig_patent_app_number] => 647383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763069 [patent_doc_number] => 05741904 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Method of producing .epsilon.-caprolactam, MFI zeolite catalysts on whose surface symmetrically arranged OH groups are present and to a method of producing them' [patent_app_type] => 1 [patent_app_number] => 8/647438 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 6746 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741904.pdf [firstpage_image] =>[orig_patent_app_number] => 647438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731043 [patent_doc_number] => 05652362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'Preparation of caprolactam' [patent_app_type] => 1 [patent_app_number] => 8/643819 [patent_app_country] => US [patent_app_date] => 1996-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5672 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 252 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652362.pdf [firstpage_image] =>[orig_patent_app_number] => 643819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688520 [patent_doc_number] => 05643918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Marcrocyclic amide and urea immunomodulators' [patent_app_type] => 1 [patent_app_number] => 8/636746 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51612 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643918.pdf [firstpage_image] =>[orig_patent_app_number] => 636746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3825855 [patent_doc_number] => 05731320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Macrocyclic amide and urea immunomodulators' [patent_app_type] => 1 [patent_app_number] => 8/633996 [patent_app_country] => US [patent_app_date] => 1996-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53171 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731320.pdf [firstpage_image] =>[orig_patent_app_number] => 633996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3667119 [patent_doc_number] => 05668277 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Depolymerization of polyamides' [patent_app_type] => 1 [patent_app_number] => 8/632082 [patent_app_country] => US [patent_app_date] => 1996-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3731 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668277.pdf [firstpage_image] =>[orig_patent_app_number] => 632082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731422 [patent_doc_number] => 05693648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'O-aryl, O-alkyl, O-alkenyl and O-alkynyl-macrolides having immunosuppressive activity' [patent_app_type] => 1 [patent_app_number] => 8/619638 [patent_app_country] => US [patent_app_date] => 1996-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80564 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3511 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693648.pdf [firstpage_image] =>[orig_patent_app_number] => 619638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3746339 [patent_doc_number] => 05716953 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => '1,5-benzodiazepine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/578535 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19210 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716953.pdf [firstpage_image] =>[orig_patent_app_number] => 578535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728608 [patent_doc_number] => 05700934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Process for the preparation of epsilon-caprolactam and epsilon-caprolactam precursors' [patent_app_type] => 1 [patent_app_number] => 8/616742 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4039 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700934.pdf [firstpage_image] =>[orig_patent_app_number] => 616742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3748490 [patent_doc_number] => 05717089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Process for the preparation of E-caprolactam' [patent_app_type] => 1 [patent_app_number] => 8/616748 [patent_app_country] => US [patent_app_date] => 1996-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7914 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/717/05717089.pdf [firstpage_image] =>[orig_patent_app_number] => 616748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648199 [patent_doc_number] => 05683999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Cyclic urea HIV protease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/613554 [patent_app_country] => US [patent_app_date] => 1996-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29528 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1744 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683999.pdf [firstpage_image] =>[orig_patent_app_number] => 613554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883141 [patent_doc_number] => 05798381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Biologically active bistramides, process for their production and their applications in therapy' [patent_app_type] => 1 [patent_app_number] => 8/513923 [patent_app_country] => US [patent_app_date] => 1996-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7227 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798381.pdf [firstpage_image] =>[orig_patent_app_number] => 513923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3731236 [patent_doc_number] => 05635504 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Diazepine containing dual action inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/609184 [patent_app_country] => US [patent_app_date] => 1996-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9537 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 314 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635504.pdf [firstpage_image] =>[orig_patent_app_number] => 609184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648480 [patent_doc_number] => 05637698 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Fused multiple ring lactams' [patent_app_type] => 1 [patent_app_number] => 8/607058 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9313 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637698.pdf [firstpage_image] =>[orig_patent_app_number] => 607058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795575 [patent_doc_number] => 05780623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Process to prepare .epsilon.-caprolactam from 6-aminocaproic acid' [patent_app_type] => 1 [patent_app_number] => 8/605883 [patent_app_country] => US [patent_app_date] => 1996-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2887 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780623.pdf [firstpage_image] =>[orig_patent_app_number] => 605883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809193 [patent_doc_number] => 05831094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Difluoro statone antiviral analogs' [patent_app_type] => 1 [patent_app_number] => 8/596336 [patent_app_country] => US [patent_app_date] => 1996-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11662 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831094.pdf [firstpage_image] =>[orig_patent_app_number] => 596336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690594 [patent_doc_number] => 05644054 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Process for preparing diltiazem' [patent_app_type] => 1 [patent_app_number] => 8/601182 [patent_app_country] => US [patent_app_date] => 1996-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1850 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/644/05644054.pdf [firstpage_image] =>[orig_patent_app_number] => 601182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769534 [patent_doc_number] => 05773428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Matrix metalloprotease inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/597062 [patent_app_country] => US [patent_app_date] => 1996-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39813 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773428.pdf [firstpage_image] =>[orig_patent_app_number] => 597062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831144 [patent_doc_number] => 05712129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity' [patent_app_type] => 1 [patent_app_number] => 8/591457 [patent_app_country] => US [patent_app_date] => 1996-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712129.pdf [firstpage_image] =>[orig_patent_app_number] => 591457 [rel_patent_id] =>[rel_patent_doc_number] =>)